Radioligand Treatment with [177Lu]Lu-PSMA I&amp;T in the Older Patients - Safety, Efficacy, and Prognostic Factors for Survival

Simon Weber; Anna Seitz; Hubert Kübler; Andreas Buck; Rudolf Werner; Philipp Hartrampf

Meeting ReportGeneral Clinical Specialties - Outcomes/Comparative Effectiveness Research & Radiation Safety

Radioligand Treatment with [177Lu]Lu-PSMA I&T in the Older Patients - Safety, Efficacy, and Prognostic Factors for Survival

Simon Weber, Anna Seitz, Hubert Kübler, Andreas Buck, Rudolf Werner and Philipp Hartrampf

Journal of Nuclear Medicine June 2024, 65 (supplement 2) 241969;

Simon Weber

1Klinik und Poliklinik für Nuklearmedizin des Universitätsklinikums Würzburg

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anna Seitz

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hubert Kübler

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Andreas Buck

2Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rudolf Werner

3Goethe University Frankfurt, University Hospital, Department of Nuclear Medicine, Clinic for Radiology and Nuclear Medicine, Frankfurt, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Philipp Hartrampf

4Department of Nuclear Medicine, University Hospital Wuerzburg

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics

Article Figures & Data

Figures

Download figure
Open in new tab
Download powerpoint

In this issue

Journal of Nuclear Medicine

Vol. 65, Issue supplement 2

June 1, 2024

Table of Contents
Index by author

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Radioligand Treatment with [177Lu]Lu-PSMA I&T in the Older Patients - Safety, Efficacy, and Prognostic Factors for Survival

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Radioligand Treatment with [177Lu]Lu-PSMA I&T in the Older Patients - Safety, Efficacy, and Prognostic Factors for Survival

Simon Weber, Anna Seitz, Hubert Kübler, Andreas Buck, Rudolf Werner, Philipp Hartrampf

Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241969;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Radioligand Treatment with [177Lu]Lu-PSMA I&T in the Older Patients - Safety, Efficacy, and Prognostic Factors for Survival

Simon Weber, Anna Seitz, Hubert Kübler, Andreas Buck, Rudolf Werner, Philipp Hartrampf

Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241969;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Info & Metrics

No related articles found.

Google Scholar

Cited By...

No citing articles found.

Google Scholar

Main menu

User menu

Search

Radioligand Treatment with [177Lu]Lu-PSMA I&T in the Older Patients - Safety, Efficacy, and Prognostic Factors for Survival

Article Figures & Data

Figures

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles